Clinical Trial Update: Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing basal-bolus insulin versus an SSRI in patients with Type 2 diabetes undergoing general surgery completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin, basal-bolus regimen (insulin)
• Selective serotonin reuptake inhibitor (SSRI)

Snippet

Sponsor: Emory University | Conditions: Type 2 Diabetes, Inpatient Hyperglycemia | Phase 4 | Status: COMPLETED | Results posted: 2014-03-12